Medtronic Neuromodulation 2023-01-18 Health serious FDA
Health · FDA · Recall #FDA-Z-0913-2023
Vanta/Seqenita LT Clinician Programmer Application, Neurostimulation systems for pain… Recall
Issued January 18, 2023 · Medtronic Neuromodulation
In January 2023, Medtronic Neuromodulation recalled the Vanta/Seqenita LT Clinician Programmer Application, Neurostimulation systems for pain…, a serious health recall reported by the FDA.
Compiled by Maya Ellison, RecallCheckr
What this means for you
Software anomalies, CP App messages: "Too Many Device Found", "Unexpected Device Error Code 1502", and "System Update Needed, Service Code 303"
What you should do
- 1 Stop using Vanta/Seqenita LT Clinician Programmer Application, Neurostimulation systems for pain… right away.
- 2 Set it aside where it won't be used by mistake.
- 3 Contact Medtronic Neuromodulation to arrange your voluntary. See the official notice below for contact details.
- 4 Keep the product until your remedy is fully processed. You may need it.
Official remedy (Voluntary):
Recall details
- Brand
- Medtronic Neuromodulation
- Category
- Health
- Recall date
- January 18, 2023
- Units affected
- Not reported
- Sold at
- Worldwide distribution.
- Recall number
- FDA-Z-0913-2023
- Made in
- United States
- Issuing agency
- FDA
In context
- Medtronic Neuromodulation has 5 recalls in our database.
- We're tracking 3,576 Health recalls in our database.
- This is the 903rd Health recall we've logged in 2023.